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Background: We experienced four Japanese patients with spontaneous retroperitoneal bleeding, a rare disease.
We categorized the clinical characteristics of spontaneous retroperitoneal bleeding in these patients treated in our
hospital and discuss the risk factors of spontaneous retroperitoneal bleeding.
Case presentation: Three of the 4 patients did not have a bleeding tendency as indicated by laboratory data
obtained at the time of retroperitoneal bleeding. The causative blood vessels were the lumbar and superior gluteal
arteries and the internal iliac artery. All patients were receiving an anticoagulant, heparin in one and nafamostat
mesilate in the other three patients. Three patients were being treated with hemodialysis or continuous
hemodiafiltration when the spontaneous retroperitoneal bleeding occurred. We achieved hemostasis with
transcatheter arterial embolization in 3 patients and with surgical hemostasis in 1 patient.
Conclusions: We suggest that in patients receiving anticoagulant therapy in whom progressive anemia and
unstable vital signs are present, spontaneous retroperitoneal bleeding should be considered as a possible cause.
Nafamostat mesilate may be one of the risk factors for spontaneous retroperitoneal bleeding.
Keywords: Spontaneous retroperitoneal bleeding, Nafamostat mesilate, Anticoagulant, HemodialysisBackground
Spontaneous retroperitoneal bleeding (SRB) is a rare dis-
ease. Most retroperitoneal bleeding is associated with
trauma, tumor, hematologic disease, thrombotic thrombo-
cytopenic purpura [1], or Evans syndrome [2]. Other than
these existing diseases, heparin is one of the reported risk
factors for SRB [3-6]. The clinical characteristics of SRB
have not been elucidated yet. We experienced four pa-
tients with SRB in our intensive care units, of whom three
patients were receiving nafamostat mesilate for anticoagu-
lation. We categorize the clinical characteristics of SRB in
these patients and discuss the risk factors for SRB.Case presentation
We experienced four Japanese patients with SRB in our in-
tensive care and emergency care units. None of the patients
had hematologic disease or congenital anomalies. We in-
vestigated the present and past medical histories, blood
test results before bleeding, therapies used, and causative
blood vessels of all four patients. SRB was diagnosed in
all patients by computed tomography (CT) imaging, and* Correspondence: yamamura@med.osaka-cu.ac.jp
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article, unless otherwise stated.no vessel malformations such as aneurysm, arteriovenous
malformation, or arteriovenous shunt were found. We
collected data relating to patient history, existing disease,
dialysis, laboratory data, treatment, and prognosis. All
patients gave their written informed consent for this
data collection.
Patient characteristics are listed in Table 1. The patients
included 2 men and 2 women (average age, 63 years).
Average platelet count before bleeding was 135,750/mm3
(range 113,000–175,000/mm3), prothrombin time (inter-
national normalized ratio) was 1.44 (range 1.03–1.84), and
the activated partial thromboplastin time was 34.2 sec
(range 30.5–39.0 sec). Only one of the three patients
showed a bleeding tendency. The causative blood vessels
were the lumbar and superior gluteal arteries and internal
iliac artery. CT images showed that three patients had
hematoma of the intra-iliopsoas muscle, and one patient
had hematoma of the retroperitoneal space (Figures 1
and 2). None of the abdominal CT images showed the
collection of any intraperitoneal fluid. We did not find
aneurysm to be the cause of bleeding in any of the pa-
tients. Bleeding points in all patients were located in the
distal portion of the causative artery on angiography, and we
also observed micro-extravasation. We achieved hemostasis
in 3 patients with transcatheter arterial embolization usingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Patient characteristics
Case 1 2 3 4
Age (yrs) 45 63 77 66
Sex Male Male Female Female
Diagnosis Post liver transplantation Fulminant hepatitis Post cardiac arrest syndrome Aneurysm of external iliac artery
Existing disease Liver cirrhosis (−) Thyroid carcinoma CRF, DM, HT
Bleeding artery SGA, LA (3) LA (3) LA (1–4) IIA
Hemodialysis CHDF CHDF (−) HD
Anticoagulant NM NM Heparin NM
PLT (×104/mm3) 17.5 11.6 11.3 13.9
PT (INR) 1.48 1.84 1.03 1.42
APTT (sec) 30.5 39.0 30.6 36.6
Treatment TAE TAE TAE Operation
Duration in supine position (days) 13 12 10 2
Outcome Survival Death Survival Survival
CRF: Chronic renal failure, DM: Diabetes mellitus, HT: Hypertension, SGA: Superior gluteal artery, LA: Lumbar artery, IIA: Internal iliac artery, CHDF: Continuous
hemodiafiltration, HD: Hemodialysis, NM: Nafamostat mesilate, PLT: Platelets, PT (INR): Prothrombin time (international normalized ratio), APTT: Activated partial
thromboplastin time, TAE: Transcatheter arterial embolization.
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surgical hemostasis. We had begun hemodialysis before
bleeding in two patients, whose durations of continuous
hemodiafiltration had been 3 to 8 days, respectively,
and one patient received hemodialysis every 3 days.Figure 1 Computed tomography and angiographic images in cases 1
giant intramuscular hematoma in the iliopsoas muscle and the active bleed
angiographic image from case 1. Extravasation was found in the superior g
abdominal CT image from case 2. A left iliopsoas muscle hematoma is sho
Multiple extravasations were found in the 3rd lumbar artery (black arrowheNafamostat mesilate was used for anticoagulation in all
three of these patients. Three of the four patients were still
alive at 1 month after the SRB incident, but the patient
with fulminant hepatitis died from multiple organ failure
on hospital day 19.and 2. Upper left panel shows abdominal CT image from case 1. A
ing point (white arrowhead) are shown. Upper right panel shows an
luteal artery area (black arrowheads). Lower left panel shows an
wn. Lower right panel shows an angiographic image from case 2.
ads).
Figure 2 Computed tomography and angiographic images in cases 3 and 4. Upper left panel shows an abdominal CT image from case 3. A
giant intramuscular hematoma in the right iliopsoas muscle is shown. Upper right panel shows an angiographic image from case 3. Extravasation
was found in the 4th lumbar artery (black arrowheads). Lower panels show abdominal CT images from case 4 (left: axial view, right: coronal view).
A giant retroperitoneal hematoma and the active bleeding point (white arrowhead) are shown.
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There are several well-recognized causes of retroperiton-
eal hematoma, including ruptured aortic aneurysm, trau-
matic vascular injury, retroperitoneal neoplasms, and
coagulopathy [1]. However, idiopathic or spontaneous
retroperitoneal hematoma is rare, and there are only a
few documented reports implicating heparin, warfarin,
low-molecular-weight heparin, or antiplatelet agents as a
potential cause [3]. As a lesson from our cases, we con-
sider administration of an anticoagulant drug and
hemodialysis to be risk factors for SRB. There are no re-
ports of nafamostat mesilate as a risk factor for SRB, to
our knowledge, and we believe this is the first report.
Nafamostat mesilate is a serine protease inhibitor used
clinically as an anti-inflammatory. It inhibits protein de-
grading enzymes such as thrombin, active form coagula-
tion factors (XIIa, Xa, and VIIa), kallikrein, plasmin, and
complements such as C1r, C1s, C3, and C5 convertases.
It is also effective in inhibiting elements in the alternate
pathway such as factors B and D. Similarly, it can coun-
ter the activation of key molecules in the coagulation
cascade such as thrombin and plasmin and is thus used
as an anticoagulant. The inhibitory action of thrombin
develops without the need for antithrombin III. The
half-life of nafamostat mesilate is short, 2–3 hours [7].
Use of nafamostat mesilate for anticoagulation is safecompared with that of heparin, and therefore, it is used
in critical patients or those with a bleeding tendency.
We recognized hemorrhage in our patients on the
basis of progressive anemia, tachycardia with low blood
pressure, and abdominal distension. Abdominal ultra-
sonography was not useful for identifying retroperitoneal
hemorrhage because none of our patients showed the
presence of any intraabdominal fluid. However, en-
hanced CT was useful for the accurate diagnosis of SRB.
Bleeding was slow in our patients, and thus it was hard
to recognize SRB in the early phase. Trans-catheter
embolization is reported to be useful in achieving
hemostasis in SRB [8]. Multiple sites of bleeding were
present in our patients, and bleeding occurred in periph-
eral arteries in three of the patients. SPONGEL® was
used as the embolic material, and complete hemostasis
was achieved in all patients with no incidents of re-
bleeding or complications.
The mechanism of SRB was not clear. A previous re-
port suggested that forceful muscular strain might be a
mechanism of SRB [9]. In our patients and in previous
reports, sites of bleeding were mostly intramuscular, oc-
curring in the posterior region of the iliopsoas or gluteal
muscles [9]. The sites of bleeding were the lumbar arter-
ies in the majority of our patients. We considered one
possible mechanism of blood vessel rupture in our
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the supine position, which resulted in compression of
the posterior side of the involved muscle. Another pos-
sible mechanism might have been muscle strain of the
iliopsoas muscle occurring during routine patient care
of which neither the nursing staff nor the patients
were aware. The patients with iliopsoas hematoma were
in the supine position for an average of 11 days (range,
10–13 days), and changing of patient position was lim-
ited because they were being treated with continuous
hemodiafiltration. Multiple sites of bleeding were present
in all but one of our patients. Although our results may
suggest that achievement of hemostasis in SRB with
transcatheter arterial embolization was more useful
than that by surgical treatment, this report included a
very small number of cases from a single center. Thus,
there is a need to collect more cases from additional
centers. Further, we could not definitively determine
that the cause of SRB was directly related to nafamostat
mesilate. However, we suggest that nafamostat mesilate
may be one risk factor for SRB.
Conclusions
We suggest that SRB should be considered as a possible
complication in patients receiving anticoagulant ther-
apy in whom progressive anemia and unstable vital
signs are present. Nafamostat mesilate may be one risk
factor for SRB.
Consent
Written informed consent was obtained from three of
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